Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma

about

Retinoblastoma, the visible CNS tumor: A review.

P2860

Q48288706-1057C838-F313-4327-A48B-E45C3F8B89E3

P2860

Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma

Item

http://www.wikidata.org/entity/Q37146786

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular analysis distinguish ...... n patients with retinoblastoma

@en

Molecular analysis distinguish ...... patients with retinoblastoma.

@nl

type

Item

label

Molecular analysis distinguish ...... n patients with retinoblastoma

@en

Molecular analysis distinguish ...... patients with retinoblastoma.

@nl

prefLabel

Molecular analysis distinguish ...... n patients with retinoblastoma

@en

Molecular analysis distinguish ...... patients with retinoblastoma.

@nl

P1476

Molecular analysis distinguish ...... n patients with retinoblastoma

@en

P2093

Beata Piovesan

http://www.w3.org/2001/XMLSchema#string

Bob Argiropoulos

http://www.w3.org/2001/XMLSchema#string

Diane Rushlow

http://www.w3.org/2001/XMLSchema#string

Donco Matevski

http://www.w3.org/2001/XMLSchema#string

Furqan Shaikh

http://www.w3.org/2001/XMLSchema#string

Heather MacDonald

http://www.w3.org/2001/XMLSchema#string

Helen S L Chan

http://www.w3.org/2001/XMLSchema#string

Hilary Racher

http://www.w3.org/2001/XMLSchema#string

Renée Perrier

http://www.w3.org/2001/XMLSchema#string

Sameh Soliman

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma

Profiling genomic copy number changes in retinoblastoma beyond loss of RB1

Prognostic factors in retinoblastoma.

One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma.

Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.

Intraocular retinoblastoma: the case for a new group classification.

National Retinoblastoma Strategy Canadian Guidelines for Care: Stratégie thérapeutique du rétinoblastome guide clinique canadien.

Detection of mosaic RB1 mutations in families with retinoblastoma.

Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951-2004.

Difficulties in diagnosing small round cell tumours of childhood from fine needle aspiration cytology samples.

P304

359-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANCERGEN.2016.06.001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

209

http://www.w3.org/2001/XMLSchema#string

P50

Timothy W. Corson

Brenda L. Gallie

P577

2016-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27318443

http://www.w3.org/2001/XMLSchema#string

P921

retinoblastoma

differential diagnosis

P932

4970893

http://www.w3.org/2001/XMLSchema#string

Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma

about

P2860

P2860

Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932